DORIPENEM News
DORIPENEM currently has 0 news articles, with 13 predicted indications.
This page combines the AI-predicted indications for DORIPENEM with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (13):
- low phospholipid associated cholelithiasis (99.0%)
- cholecystitis (99.0%)
- pyelonephritis (99.0%)
- idiopathic copper-associated cirrhosis (99.0%)
- hepatopulmonary syndrome (99.0%)
- early-onset familial noncirrhotic portal hypertension (99.0%)
- hepatoportal sclerosis (99.0%)
- primitive portal vein thrombosis (99.0%)
- hepatic porphyria (99.0%)
- genetic otorhinolaryngological malformation (98.7%)
- juvenile nasopharyngeal angiofibroma (disease) (98.6%)
- neonatal epileptic encephalopathy due to glutaminase deficiency (98.5%)
- familial nasal acilia (98.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.